English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 178 Help

Selected(0)Clear Items/Page:    Sort:
Identification of JAZF1, KNOP1, and PLEKHA1 as causally associated genes and drug targets for Alzheimer’s disease: a summary data-based Mendelian randomization study Journal article
Zhai, Yuhan, Li, Ning, Zhang, Yujie, Li, Haibin, Wu, Lijuan, Wei, Cuibai, Ji, Jianguang, Zheng, Deqiang. Identification of JAZF1, KNOP1, and PLEKHA1 as causally associated genes and drug targets for Alzheimer’s disease: a summary data-based Mendelian randomization study[J]. Inflammopharmacology, 2024, 32(6), 3913-3923.
Authors:  Zhai, Yuhan;  Li, Ning;  Zhang, Yujie;  Li, Haibin;  Wu, Lijuan; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.6/4.5 | Submit date：2024/11/05
Alzheimer’s Disease  Causal Association  Immune Cells  Summary-data-based Mendelian Randomization  
A Supramolecular Protein Assembly Intrinsically Rescues Memory Deficits in an Alzheimer’s Disease Mouse Model Journal article
Hao, Yuchong, Shen, Xin, Liu, Jiantao, Cai, Zhongqi, Wang, Xinquan, Yang, Zerui, Chen, Fuqing, Dong, Baorui, Wang, Ruibing, Du, Xiubo, Qi, Zhenhui, Ge, Yan. A Supramolecular Protein Assembly Intrinsically Rescues Memory Deficits in an Alzheimer’s Disease Mouse Model[J]. Nano Letters, 2024, 24(49), 15565−15574.
Authors:  Hao, Yuchong;  Shen, Xin;  Liu, Jiantao;  Cai, Zhongqi;  Wang, Xinquan; et al.
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:9.6/10.1 | Submit date：2024/12/05
Alzheimer’s Disease  Blood-brain Barrier  Nanodisc  Nanomedicine  Protein Assembly  
An integrated strategy for in-depth profiling of N-acylethanolamines in biological samples by UHPLC-HRMS Journal article
Zhou, Jun Yi, Chen, Yan Qing, Hu, Guang, Zhao, Haiyu, Wan, Jian Bo. An integrated strategy for in-depth profiling of N-acylethanolamines in biological samples by UHPLC-HRMS[J]. Analytica Chimica Acta, 2024, 1329, 343262.
Authors:  Zhou, Jun Yi;  Chen, Yan Qing;  Hu, Guang;  Zhao, Haiyu;  Wan, Jian Bo
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:5.7/5.5 | Submit date：2024/10/10
Alzheimer's Disease  Chemical Derivatization  N-acylethanolamides  Parallel Reaction Monitoring  Uhplc-hrms  
Endothelial Dysfunctions in Blood–Brain Barrier Breakdown in Alzheimer's Disease: From Mechanisms to Potential Therapies Review article
2024
Authors:  Yue, Qian;  Leng, Xinyue;  Xie, Ningqing;  Zhang, Zaijun;  Yang, Deguang; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.8/5.9 | Submit date：2024/12/05
Alzheimer's Disease  Bbb Protection  Blood–brain Barrier  Influx And Efflux Transporter  Paracellular Permeability  Vascular Inflammation  
YOD1 regulates microglial homeostasis by deubiquitinating MYH9 to promote the pathogenesis of Alzheimer's disease Journal article
Jinfeng Sun, Fan Chen, Lingyu She, Yuqing Zeng, Hao Tang, Bozhi Ye, ZHENG WENHUA, Li Xiong, Liwei Li, Luyao Li, Qin Yu, Linjie Chen, Wei Wang, Guang Liang, Xia Zhao. YOD1 regulates microglial homeostasis by deubiquitinating MYH9 to promote the pathogenesis of Alzheimer's disease[J]. Acta Pharmaceutica Sinica B, 2024.
Authors:  Jinfeng Sun;  Fan Chen;  Lingyu She;  Yuqing Zeng;  Hao Tang; et al.
Favorite | TC[Scopus]:0  IF:14.7/14.1 | Submit date：2024/08/31
Alzheimer’s Disease  Yod1  Myosin Heavy Chain 9  Microglia  Inflammation  Cognitive Dysfunction  Neurotoxicity  Synaptic Function  
Endothelial Dysfunctions in Blood–Brain Barrier Breakdown in Alzheimer's Disease: From Mechanisms to Potential Therapies Journal article
Yue, Qian, Leng, Xinyue, Xie, Ningqing, Zhang, Zaijun, Yang, Deguang, Hoi, Maggie Pui Man. Endothelial Dysfunctions in Blood–Brain Barrier Breakdown in Alzheimer's Disease: From Mechanisms to Potential Therapies[J]. CNS Neuroscience and Therapeutics, 2024, 30(11), e70079.
Authors:  Yue, Qian;  Leng, Xinyue;  Xie, Ningqing;  Zhang, Zaijun;  Yang, Deguang; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.8/5.9 | Submit date：2024/12/26
Alzheimer's Disease  Bbb Protection  Blood–brain Barrier  Influx And Efflux Transporter  Paracellular Permeability  Vascular Inflammation  
Artemisinin inhibits neuronal ferroptosis in Alzheimer's disease models by targeting KEAP1 Journal article
Peng-xi Deng, Marta Silva, Na Yang, Qing Wang, Xin Meng, Ke-qiang Ye, Hong-chang Gao, ZHENG WENHUA. Artemisinin inhibits neuronal ferroptosis in Alzheimer's disease models by targeting KEAP1[J]. Acta Pharmacologica Sinica, 2024.
Authors:  Peng-xi Deng;  Marta Silva;  Na Yang;  Qing Wang;  Xin Meng; et al.
Favorite | TC[WOS]:1 TC[Scopus]:0  IF:6.9/7.6 | Submit date：2024/08/31
Alzheimer's Disease  Artemisinin  Ferroptosis  Keap1  Nrf2  Hippocampus  
Sigma-1 receptor positive allosteric modulator promotes the neuronal survival and improves cognitive deficits in AD mice via Sigma-1 receptor/ERK pathway Conference paper
Xiaoyu Wang, Wenhua Zheng. Sigma-1 receptor positive allosteric modulator promotes the neuronal survival and improves cognitive deficits in AD mice via Sigma-1 receptor/ERK pathway[C], 2024.
Authors:  Xiaoyu Wang;  Wenhua Zheng
Favorite |  | Submit date：2024/08/31
Alzheimer's Disease, Somcl-668, Neuronal Cells, 3xtg-ad Mice, Sigma-1 Receptor/erk/creb Pathway  
Artemisinin protects against neural injury by targeting KEAP1 to inhibit ferroptosis in Alzheimer’s disease models Conference paper
Pengxi DENG, ZHENG WENHUA. Artemisinin protects against neural injury by targeting KEAP1 to inhibit ferroptosis in Alzheimer’s disease models[C], 2024.
Authors:  Pengxi DENG;  ZHENG WENHUA
Favorite |  | Submit date：2024/08/31
Artemisinin, Ferroptosis, Keap1, Nrf2, Alzheimer's Disease (Ad).  
Artemisinin Alleviates Astrocyte Over-Activation and Neuroinflammation by modulating the IRE1/NF-κB Signaling Pathway in in vitro and in vivo Alzheimer's Disease Models Conference paper
Lei Chen, ZHENG WENHUA. Artemisinin Alleviates Astrocyte Over-Activation and Neuroinflammation by modulating the IRE1/NF-κB Signaling Pathway in in vitro and in vivo Alzheimer's Disease Models[C], 2024.
Authors:  Lei Chen;  ZHENG WENHUA
Favorite |  | Submit date：2024/08/31
Alzheimer’s Disease  Endoplasmic Reticulum Stress  Artemisinin  Astrocyte  3xtg Ad Mice  Neuroinflammation  Ire1  Nf-κb.